Late recurrences of histiocytic lymphoma after treatment
- 15 June 1984
- Vol. 53 (12), 2663-2667
- https://doi.org/10.1002/1097-0142(19840615)53:12<2663::aid-cncr2820531216>3.0.co;2-y
Abstract
Disease-free intervals of 2 to 3 years after treatment of histiocytic lymphoma are generally thought to represent cures; flat survival curves beyond 3 years in several studies support this notion. Four case reports of histiocytic lymphoma recurrences 25, 10, 9 and 6 years, respectively, after the initial diagnosis are presented. Histologic confirmation comparing primary and recurrent disease is presented. The potential biological significance of such patient reports is discussed.This publication has 20 references indexed in Scilit:
- Distinctive Chromosomal Abnormalities in Histologic Subtypes of Non-Hodgkin's LymphomaNew England Journal of Medicine, 1982
- Burkitt's LymphomaNew England Journal of Medicine, 1981
- Childhood Social Environment and Hodgkin's DiseaseNew England Journal of Medicine, 1981
- Immunologic Phenotype in 30 Patients with Diffuse Large-Cell LymphomaNew England Journal of Medicine, 1980
- Cost Containment: A Statement by the American Surgical AssociationNew England Journal of Medicine, 1979
- Occurrence of Non-Hodgkin's Lymphoma after Therapy for Hodgkin's DiseaseNew England Journal of Medicine, 1979
- CHEMOTHERAPY OF LOCALISED HISTIOCYTIC LYMPHOMAThe Lancet, 1979
- Concepts for systemic treatment of micrometastasesCancer, 1975
- The persistence of Hodgkin's disease in long-term survivorsAmerican Journal Of Medicine, 1971
- Influence of the Concentration of Leukemic Inoculum on the Effectiveness of TreatmentScience, 1956